Access the full text.
Sign up today, get DeepDyve free for 14 days.
(1989)
2′,3′-dideoxy-5-substituted uridines
A. Erice, H. Balfour, D. Myers, V. Leske, K. Sannerud, V. Kuebelbeck, J. Irvin, F. Uckun (1993)
Anti-human immunodeficiency virus type 1 activity of an anti-CD4 immunoconjugate containing pokeweed antiviral proteinAntimicrobial Agents and Chemotherapy, 37
d 4 T - 5 ′ - [ p - bro - mophenyl methoxyalaninyl phosphate ] as a potent and non - toxic anti - HIV agent
E. McIntee, R. Remmel, R. Schinazi, T. Abraham, C. Wagner (1997)
Probing the mechanism of action and decomposition of amino acid phosphomonoester amidates of antiviral nucleoside prodrugs.Journal of medicinal chemistry, 40 21
T. Venkatachalam, H. Tai, R. Vig, C. Chen, S. Jan, F. Uckun (1998)
Enhancing effects of a mono-bromo substitution at the para position of the phenyl moiety on the metabolism and anti-HIV activity of d4T-phenyl methoxyalaninyl phosphate derivatives.Bioorganic & medicinal chemistry letters, 8 22
R. Vig, T. Venkatachalam, S. Jan, F. Uckun (1998)
Aryl phosphate derivatives of 3'-deoxythymidine are not potent anti-human immunodeficiency virus agents.Antiviral chemistry & chemotherapy, 9 5
J. Zarling, P. Moran, O. Haffar, J. Sias, D. Richman, C. Spina, D. Myers, V. Kuebelbeck, J. Ledbetter, F. Uckun (1990)
Inhibition of HIV replication by pokeweed antiviral protein targeted to CD4+ cells by monoclonal antibodiesNature, 347
(1993)
Inhibition of zidovudine ( AZT ) - sensitive strains of human immuno deficiency virus type 1 by pokeweed antiviral protein targeted to CD 4 + cells
C. Mcguigan*, D. Cahard, H. Sheeka, E. Clercq, J. Balzarini (1996)
Aryl phosphoramidate derivatives of d4T have improved anti-HIV efficacy in tissue culture and may act by the generation of a novel intracellular metabolite.Journal of medicinal chemistry, 39 8
C. Mcguigan*, D. Cahard, H. Sheeka, E. Clercq, J. Balzarini (1996)
Phosphoramidate derivatives of d4T with improved anti-HIV efficacy retain full activity in thymidine kinase-deficient cellsBioorganic & Medicinal Chemistry Letters, 6
(1986)
Phosphorylation of 3′-azido3′deoxythymidine and selective interaction of the 5′-triphosphate
C. Mcguigan*, R. Pathirana, N. Mahmood, K. Devine, A. Hay (1992)
Aryl phosphate derivatives of AZT retain activity against HIV1 in cell lines which are resistant to the action of AZT.Antiviral research, 17 4
J. Balzarini, P. Herdewijn, E. Clercq (1989)
Differential patterns of intracellular metabolism of 2',3'-didehydro-2',3'-dideoxythymidine and 3'-azido-2',3'-dideoxythymidine, two potent anti-human immunodeficiency virus compounds.The Journal of biological chemistry, 264 11
(1989)
2 ′ , 3 ′ - dideoxy - 5 - substituted uridines and related compounds as antiviral agents
F. Uckun, L. Chelstrom, L. Tuel-ahlgren, I. Dibirdik, J. Irvin, Mridula-Chandan Langlie, D. Myers (1998)
TXU (Anti-CD7)-Pokeweed Antiviral Protein as a Potent Inhibitor of Human Immunodeficiency VirusAntimicrobial Agents and Chemotherapy, 42
R. Vig, T. Venkatachalam, F. Uckun (1998)
D4T-5'-[p-bromophenyl methoxyalaninyl phosphate] as a potent and non-toxic anti-human immunodeficiency virus agent.Antiviral chemistry & chemotherapy, 9 5
Phillip FURMANt, A. James, FYFEf, M. CLAIRt, K. Weinhold, J. Rideout, G. Freeman, Sandra LEHRMANt, Samuel, Broder, H. Mitsuya, David BARRYt (1986)
Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase.Proceedings of the National Academy of Sciences of the United States of America, 83 21
C. Mcguigan*, R. Pathirana, J. Balzarini, E. Clercq (1993)
Intracellular delivery of bioactive AZT nucleotides by aryl phosphate derivatives of AZT.Journal of medicinal chemistry, 36 8
Z. Hao, D. Cooney, N. Hartman, C. Perno, A. Fridland, A. Devico, M. Sarngadharan, S. Broder, D. Johns (1988)
Factors determining the activity of 2',3'-dideoxynucleosides in suppressing human immunodeficiency virus in vitro.Molecular pharmacology, 34 4
The potency and selectivity index of the AZT-phenyl phosphate derivatives in thymidine kinase (TK)-deficient T cells were substantially enhanced by introducing a single para-bromo substituent in the phenyl moiety. AZT-5′-(p-bromophenyl methoxyalaninyl phosphate) was 43-fold more potent than AZT-5′-(phenyl methoxyalaninyl phosphate) and was fivefold more potent than AZT in inhibiting human immunodeficiency virus (HIV) replication in TK-deficient CEM cells.
Antiviral Chemistry and Chemotherapy – SAGE
Published: Jun 23, 2016
Keywords: AZT derivatives,HIV,thymidine kinase-deficient T cells
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.